The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Orth Andrew C. since 2023.
This trader's CIK number is 1860010.
At the time of last reporting, Orth Andrew C. was the Chief Commercial Officer of Krystal Biotech, Inc.. (stock ticker symbol KRYS).
Also see all insider trading activities at Krystal Biotech, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | KRYS | 0 | $0 | 12,500 | $1,611,437 | 12,500 | $794,375 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-06-09 | KRYS | Sale | 12,500 | 128.91 | 1,611,437 |
| 2023-06-09 | KRYS | Option Ex | 12,500 | 63.55 | 794,375 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Orth Andrew C. (Chief Commercial Officer of Krystal Biotech, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.